AOD9604 6mg

AOD9604 6mg

$ 65,00

AOD-9604 is a research peptide consisting of amino acids 177–191 of the human growth hormone sequence. Studies indicate it modulates lipid and glucose metabolism pathways without influencing IGF-1 activity, acting primarily through β-adrenergic and AMPK-related mechanisms. It is commonly used in metabolic and adipocyte differentiation research to elucidate downstream energy regulation signaling.

For research use only. Not for human consumption.

Category:

Description

AOD9604 is a synthetic peptide derived from a specific fragment of human growth hormone (HGH). Unlike HGH itself, AOD9604 was designed to isolate and replicate only the fat-metabolizing effects of growth hormone, without triggering its growth-promoting or insulin-altering actions.

It has primarily been studied and used in the context of fat loss and metabolic support, rather than muscle growth or hormonal enhancement.

How AOD9604 Works

AOD9604 acts directly on fat cells, influencing lipid metabolism without stimulating the pituitary gland or increasing IGF-1 levels.

Its key actions include:

  • Promoting lipolysis (the breakdown of stored fat)

  • Inhibiting lipogenesis (the formation of new fat)

  • Supporting overall metabolic efficiency

Because it does not activate the full HGH pathway, AOD9604 avoids many of the systemic hormonal effects associated with growth hormone therapies.

Potential Benefits

Based on research and reported use, AOD9604 may offer:

  • Support for targeted fat loss

  • Reduction in stubborn or resistant fat

  • Improved metabolic signaling

  • Assistance with weight management when combined with diet and exercise

Its effects are typically subtle and best viewed as a supportive tool, not a standalone solution.

Administration

  • Commonly administered via subcutaneous injection

  • The 6 mg strength usually refers to the total amount supplied per vial

  • Often used daily or in short cycles, depending on protocol

Because it does not significantly affect hormone levels, it is sometimes used alongside other peptides or metabolic therapies.

Safety and Tolerability

AOD9604 is generally considered well tolerated. In available studies and clinical use, it has not been shown to:

  • Increase IGF-1

  • Disrupt blood glucose regulation

  • Cause growth hormone related side effects

Reported side effects are uncommon and typically mild, such as temporary injection site irritation.

Properties
Molecular Formula C78H123N23O23S2
Molecular Weight 1815.1
Monoisotopic Mass 1813.86035961
Polar Area 815
Complexity 3710
XLogP -4.8
Heavy Atom Count 126
Hydrogen Bond Donor Count 28
Hydrogen Bond Acceptor Count 28
Rotatable Bond Count 45
PubChem LCSS Aod-9604 Laboratory Chemical Safety Summary
Identifiers
CID 71300630
InChI InChI=1S/C78H123N23O23S2/c1-9-41(8)62(101-68(115)47(18-14-28-86-78(83)84)91-69(116)50(29-38(2)3)95-63(110)45(79)30-43-19-21-44(104)22-20-43)75(122)100-61(40(6)7)74(121)94-49(23-25-56(80)105)67(114)98-55-37-126-125-36-54(65(112)88-32-57(106)89-51(76(123)124)31-42-15-11-10-12-16-42)97-70(117)52(34-102)90-58(107)33-87-64(111)48(24-26-59(108)109)93-73(120)60(39(4)5)99-71(118)53(35-103)96-66(113)46(92-72(55)119)17-13-27-85-77(81)82/h10-12,15-16,19-22,38-41,45-55,60-62,102-104H,9,13-14,17-18,23-37,79H2,1-8H3,(H2,80,105)(H,87,111)(H,88,112)(H,89,106)(H,90,107)(H,91,116)(H,92,119)(H,93,120)(H,94,121)(H,95,110)(H,96,113)(H,97,117)(H,98,114)(H,99,118)(H,100,122)(H,101,115)(H,108,109)(H,123,124)(H4,81,82,85)(H4,83,84,86)/t41-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,60-,61-,62-/m0/s1
InChIKey GVIYUKXRXPXMQM-BPXGDYAESA-N
Isometric SMILES CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCNC(=N)N)CO)C(C)C)CCC(=O)O)CO)C(=O)NCC(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CC=C(C=C3)O)N
Canonical SMILES CCC(C)C(C(=O)NC(C(C)C)C(=O)NC(CCC(=O)N)C(=O)NC1CSSCC(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCCNC(=N)N)CO)C(C)C)CCC(=O)O)CO)C(=O)NCC(=O)NC(CC2=CC=CC=C2)C(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CC3=CC=C(C=C3)O)N
IUPAC Name (2S)-2-[[2-[[(4R,7S,13S,16S,19S,22S,25R)-25-[[(2S)-5-amino-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylpentanoyl]amino]-3-methylbutanoyl]amino]-5-oxopentanoyl]amino]-22-(3-carbamimidamidopropyl)-13-(2-carboxyethyl)-7,19-bis(hydroxymethyl)-6,9,12,15,18,21,24-heptaoxo-16-propan-2-yl-1,2-dithia-5,8,11,14,17,20,23-heptazacyclohexacosane-4-carbonyl]amino]acetyl]amino]-3-phenylpropanoic acid

2D Struc

Reviews

There are no reviews yet.

Be the first to review “AOD9604 6mg”

Your email address will not be published. Required fields are marked *

Related products

Reviews

There are no reviews yet.

Be the first to review “AOD9604 6mg”

Your email address will not be published. Required fields are marked *